vs
Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and STEM, INC. (STEM). Click either name above to swap in a different company.
PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($76.4M vs $47.1M, roughly 1.6× STEM, INC.). STEM, INC. runs the higher net margin — -33.9% vs -39.1%, a 5.2% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (11.9% vs -15.6%). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs 31.0%).
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
PRCT vs STEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $76.4M | $47.1M |
| Net Profit | $-29.8M | $-16.0M |
| Gross Margin | 60.6% | 48.9% |
| Operating Margin | -40.6% | -17.7% |
| Net Margin | -39.1% | -33.9% |
| Revenue YoY | 11.9% | -15.6% |
| Net Profit YoY | -58.3% | 68.8% |
| EPS (diluted) | $-0.54 | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $76.4M | $47.1M | ||
| Q3 25 | $83.3M | $38.2M | ||
| Q2 25 | $79.2M | $38.4M | ||
| Q1 25 | $69.2M | $32.5M | ||
| Q4 24 | $68.2M | $55.8M | ||
| Q3 24 | $58.4M | $29.3M | ||
| Q2 24 | $53.4M | $34.0M | ||
| Q1 24 | $44.5M | $25.5M |
| Q4 25 | $-29.8M | $-16.0M | ||
| Q3 25 | $-21.4M | $-23.8M | ||
| Q2 25 | $-19.6M | $202.5M | ||
| Q1 25 | $-24.7M | $-25.0M | ||
| Q4 24 | $-18.9M | $-51.1M | ||
| Q3 24 | $-21.0M | $-148.3M | ||
| Q2 24 | $-25.6M | $-582.3M | ||
| Q1 24 | $-26.0M | $-72.3M |
| Q4 25 | 60.6% | 48.9% | ||
| Q3 25 | 64.8% | 35.5% | ||
| Q2 25 | 65.4% | 33.4% | ||
| Q1 25 | 63.9% | 32.4% | ||
| Q4 24 | 64.0% | -4.4% | ||
| Q3 24 | 63.2% | 21.2% | ||
| Q2 24 | 59.0% | 27.6% | ||
| Q1 24 | 56.2% | -95.0% |
| Q4 25 | -40.6% | -17.7% | ||
| Q3 25 | -27.8% | -33.6% | ||
| Q2 25 | -28.0% | -34.8% | ||
| Q1 25 | -39.7% | -65.0% | ||
| Q4 24 | -28.9% | -84.4% | ||
| Q3 24 | -38.4% | -493.2% | ||
| Q2 24 | -50.3% | -1705.5% | ||
| Q1 24 | -62.1% | -267.0% |
| Q4 25 | -39.1% | -33.9% | ||
| Q3 25 | -25.7% | -62.2% | ||
| Q2 25 | -24.7% | 527.8% | ||
| Q1 25 | -35.8% | -76.9% | ||
| Q4 24 | -27.6% | -91.6% | ||
| Q3 24 | -35.9% | -506.3% | ||
| Q2 24 | -48.0% | -1712.6% | ||
| Q1 24 | -58.3% | -283.9% |
| Q4 25 | $-0.54 | $-4.40 | ||
| Q3 25 | $-0.38 | $-2.84 | ||
| Q2 25 | $-0.35 | $-1.79 | ||
| Q1 25 | $-0.45 | $-0.15 | ||
| Q4 24 | $-0.34 | $-15.29 | ||
| Q3 24 | $-0.40 | $-18.24 | ||
| Q2 24 | $-0.50 | $-71.81 | ||
| Q1 24 | $-0.51 | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $286.5M | $48.9M |
| Total DebtLower is stronger | $51.6M | — |
| Stockholders' EquityBook value | $365.9M | $-249.4M |
| Total Assets | $508.1M | $308.9M |
| Debt / EquityLower = less leverage | 0.14× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $286.5M | $48.9M | ||
| Q3 25 | $294.3M | $43.1M | ||
| Q2 25 | $302.7M | $40.8M | ||
| Q1 25 | $316.2M | $58.6M | ||
| Q4 24 | $333.7M | $56.3M | ||
| Q3 24 | $196.8M | $75.4M | ||
| Q2 24 | $214.1M | $89.6M | ||
| Q1 24 | $225.6M | $112.8M |
| Q4 25 | $51.6M | — | ||
| Q3 25 | $51.6M | — | ||
| Q2 25 | $51.5M | — | ||
| Q1 25 | $51.5M | — | ||
| Q4 24 | $51.5M | — | ||
| Q3 24 | $51.4M | — | ||
| Q2 24 | $51.4M | — | ||
| Q1 24 | $51.4M | — |
| Q4 25 | $365.9M | $-249.4M | ||
| Q3 25 | $380.3M | $-235.7M | ||
| Q2 25 | $385.8M | $-214.1M | ||
| Q1 25 | $389.2M | $-417.5M | ||
| Q4 24 | $402.2M | $-398.4M | ||
| Q3 24 | $241.2M | $-344.1M | ||
| Q2 24 | $251.8M | $-203.2M | ||
| Q1 24 | $264.0M | $371.6M |
| Q4 25 | $508.1M | $308.9M | ||
| Q3 25 | $511.5M | $362.6M | ||
| Q2 25 | $513.1M | $379.2M | ||
| Q1 25 | $519.4M | $405.1M | ||
| Q4 24 | $534.0M | $437.4M | ||
| Q3 24 | $374.1M | $537.8M | ||
| Q2 24 | $374.4M | $691.5M | ||
| Q1 24 | $382.9M | $1.3B |
| Q4 25 | 0.14× | — | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | 0.13× | — | ||
| Q1 25 | 0.13× | — | ||
| Q4 24 | 0.13× | — | ||
| Q3 24 | 0.21× | — | ||
| Q2 24 | 0.20× | — | ||
| Q1 24 | 0.19× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-10.3M | $8.2M |
| Free Cash FlowOCF − Capex | $-12.2M | — |
| FCF MarginFCF / Revenue | -15.9% | — |
| Capex IntensityCapex / Revenue | 2.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-58.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-10.3M | $8.2M | ||
| Q3 25 | $-6.6M | $11.4M | ||
| Q2 25 | $-15.0M | $-21.3M | ||
| Q1 25 | $-17.0M | $8.5M | ||
| Q4 24 | $-32.4M | $-14.7M | ||
| Q3 24 | $-18.8M | $-9.4M | ||
| Q2 24 | $-15.7M | $-11.9M | ||
| Q1 24 | $-32.3M | $-621.0K |
| Q4 25 | $-12.2M | — | ||
| Q3 25 | $-9.5M | — | ||
| Q2 25 | $-17.8M | — | ||
| Q1 25 | $-18.8M | — | ||
| Q4 24 | $-33.6M | — | ||
| Q3 24 | $-19.0M | — | ||
| Q2 24 | $-16.8M | — | ||
| Q1 24 | $-34.2M | — |
| Q4 25 | -15.9% | — | ||
| Q3 25 | -11.4% | — | ||
| Q2 25 | -22.5% | — | ||
| Q1 25 | -27.2% | — | ||
| Q4 24 | -49.2% | — | ||
| Q3 24 | -32.6% | — | ||
| Q2 24 | -31.4% | — | ||
| Q1 24 | -76.9% | — |
| Q4 25 | 2.4% | — | ||
| Q3 25 | 3.4% | — | ||
| Q2 25 | 3.5% | — | ||
| Q1 25 | 2.7% | — | ||
| Q4 24 | 1.7% | — | ||
| Q3 24 | 0.4% | — | ||
| Q2 24 | 2.0% | — | ||
| Q1 24 | 4.4% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRCT
| Hand Pieces And Other Consumables | $34.1M | 45% |
| System Sales And Rentals | $27.5M | 36% |
| Other | $9.8M | 13% |
| Service Revenue | $5.0M | 7% |
STEM
Segment breakdown not available.
